CN103028080A - Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis - Google Patents
Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis Download PDFInfo
- Publication number
- CN103028080A CN103028080A CN201210022711XA CN201210022711A CN103028080A CN 103028080 A CN103028080 A CN 103028080A CN 201210022711X A CN201210022711X A CN 201210022711XA CN 201210022711 A CN201210022711 A CN 201210022711A CN 103028080 A CN103028080 A CN 103028080A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- traditional chinese
- blood stasis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis. Traditional Chinese medicine doctors believe that the qi-stagnancy and blood stasis prostatitis belongs to the category of stranguria with turbid discharge and is mainly caused by retention of damp-heat and stagnation of turbid stasis. The traditional Chinese medicine decoction uses the traditional Chinese medicines with the efficacy of promoting blood circulation, removing blood stasis and promoting qi circulation to remove meridian obstruction including rhizoma ligustici wallichii, rhizoma corydalis, radix curcumae, leonurus heterophllus, turbid stasis, radix achyranthis bidentatae, caulis spatholobi, amomum cardamomum, cortex magnoliae officinalis, lignum santali albi and rhizoma cyperi, which are prepared into the decoction by the Preparation Room of Yishui Central Hospital of Linyi City, Shandong Province. The total effective rate of the medicine reaches 89.3 percent based on the clinical practice, which is obviously better than the control group; and the traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis is worthy of clinical popularization and application.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine decoction for the treatment of chronic prostatitis.
Background technology
Chronic prostatitis is commonly encountered diseases, the frequently-occurring disease of Urology Surgery, also is refractory disease, comprises chronic bacterial prostatitis, chronic nonbacterial prostatitis and prostatodynia.Clinical account for about 1/3 of Urology Surgery male case take prime of life male morbidity as more, and the trend that rises is year by year arranged, its primary disease course of disease is touching, and relapse rate is high.Doctor trained in Western medicine is mainly take antibiotic therapy as main, and a large amount of clinical practices show that the chronic bacterial prostatitis proportion is less than 10%, simultaneously because prostatic specific position and anatomy relationship, most medicines are difficult to play a role, facts have proved that in a large number the traditional Chinese medical science has its unique curative effect and advantage in the treatment chronic prostatitis.
Summary of the invention
The purpose of this invention is to provide a kind of prostatitic Chinese medicine QIANLIEKANG of qi stagnation and blood stasis type decoction for the treatment of.The traditional Chinese medical science thinks that primary disease belongs to the stranguria with turbid discharge category, and the turbid retardance of damp-heat accumulation and the stasis of blood is the Etiological place of primary disease, clinically take blood circulation promoting and blood stasis dispelling, promoting of the circulation of QI and removing the obstruction in the collaterals as the rule for the treatment of.
The objective of the invention is to be achieved through the following technical solutions, the prostatitic Chinese medicine QIANLIEKANG of this treatment qi stagnation and blood stasis type decoction is made by the Chinese medicine of following weight portion: Rhizoma Chuanxiong 7-9 part, Rhizoma Corydalis 10-12 part, Radix Curcumae 6-8 part, Herba Leonuri 12-15 part, Radix Achyranthis Bidentatae 7-9 part, Caulis Spatholobi 5-7 part, Fructus Amomi Rotundus 10-12 part, Cortex Magnoliae Officinalis 12-15 part, Lignum Santali Albi 7-9 part, Rhizoma Cyperi 5-7 part.
Preferably, the prostatitic Chinese medicine QIANLIEKANG of this treatment qi stagnation and blood stasis type decoction is made by the Chinese medicine of following weight portion: 8 parts of Rhizoma Chuanxiongs, 11 parts of Rhizoma Corydalis, 7 parts of Radix Curcumaes, 13 parts of Herba Leonuris, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Caulis Spatholobis, 11 parts of Fructus Amomi Rotunduss, 13 parts of Cortex Magnoliae Officinalis, 8 parts in Lignum Santali Albi, 6 parts of Rhizoma Cyperis.
In the side: Rhizoma Chuanxiong, Rhizoma Corydalis, Radix Curcumae blood-activating and qi-promoting, wind-expelling pain-stopping, resolving depression mood; Herba Leonuri, Caulis Spatholobi, Radix Achyranthis Bidentatae promoting blood circulation to restore menstrual flow, relaxing muscles and tendons and activating QI and blood in the collateral; Fructus Amomi Rotundus, Cortex Magnoliae Officinalis circulation of qi promoting are wet dry, the warming middle-JIAO removing food stagnancy; Lignum Santali Albi, Rhizoma Cyperi depressed liver-energy dispersing and QI regulating are during cold expelling is transferred.
Clinical data
1, physical data is originally organized 156 routine cases and is my institute outpatient service and the inpatient in year October in May, 2007 to 2008, all meets the diagnostic criteria of chronic prostatitis in " practical combination of Chinese and Western medicine diagnoses and treatment ".The patient is divided into two groups at random, treatment group 84 examples, matched group 72 examples.18 years old~30 years old treatment group age person's 42 examples, 31 years old~40 years old person's 30 examples, 41 years old~50 years old person's 12 examples; Course of disease half a year~1 year person 18 examples, 1 year~2 years person's 30 examples, 2 years~3 years person's 24 examples, person's 12 examples more than>3 years.18 years old~30 years old matched group age person's 30 examples, 31 years old~40 years old person's 24 examples, 41 years old~50 years old person's 18 examples; Course of disease half a year~1 year person 10 examples, 1 year~2 years person's 26 examples, 2 years~3 years person's 24 examples, person's 12 examples more than>3 years.Two groups of ages, courses of disease compare, and no significant difference (P>0.05) has comparability.
2, the Therapeutic Method treatment group is taken QIANLIEKANG decoction of the present invention.Get Rhizoma Chuanxiong 8g, Rhizoma Corydalis 11g, Radix Curcumae 7g, Herba Leonuri 13g, Radix Achyranthis Bidentatae 8g, Caulis Spatholobi 6g, Fructus Amomi Rotundus 11g, Cortex Magnoliae Officinalis 13g, Lignum Santali Albi 8g, Rhizoma Cyperi 6g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.Matched group is taken the QIANLIEKANG PIAN that Zhejiang Kang Enbei pharmaceutical Co. Ltd produces, every 0.5g, each 3~4,3 times on the one.Two groups all take 15 days as a course for the treatment of, finish 2 courses for the treatment of news commentary constant current modulation effect.Period in a medicine other antagonism cooperative drug of stopping using.
3, criterion of therapeutical effect recovery from illness: the clinical symptoms integration reduces 〉=95%, and the prostate tenderness disappears, and quality is normal or approaching normal, and EPS checks continuous normal more than 2 times; Effectively: the clinical symptoms integration reduces 30%~95%, and prostate tenderness and quality all have clear improvement.EPS checks the continuous front minimizing 30%~60% for the treatment of of WBC counting more than 2 times; Invalid: all without improving, EPS checks the continuous front minimizing<30% or unchanged for the treatment of of WBC counting more than 2 times for clinical symptoms integration minimizing<30% or unchanged, prostate tenderness and quality.
4, therapeutic outcome
(1) curative effect relatively.Treatment group 84 examples, 32 examples of wherein fully recovering (38.1%), effective 43 examples (51.2%), no effect 9 (10.7%), total effective rate 89.3%; Matched group 72 examples, 19 examples of wherein fully recovering (26.4%), effective 27 examples (37.5%), invalid 26 examples (36.1%), total effective rate 63.9%; The curative effect for the treatment of group is better than matched group (P<0.05).
(2) the NIH-CPSI scoring is observed.Two groups of rear patients' for the treatment of pain, the symptom of urinating and quality of life all is improved (all P<0.05) before the treatment, but treatment group improvement in these areas also all is better than matched group (P<0.05).
The specific embodiment
Embodiment one: take by weighing Rhizoma Chuanxiong 8g, Rhizoma Corydalis 11g, Radix Curcumae 7g, Herba Leonuri 13g, Radix Achyranthis Bidentatae 8g, Caulis Spatholobi 6g, Fructus Amomi Rotundus 11g, Cortex Magnoliae Officinalis 13g, Lignum Santali Albi 8g, Rhizoma Cyperi 6g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.
Embodiment two: take by weighing Rhizoma Chuanxiong 9g, Rhizoma Corydalis 10g, Radix Curcumae 8g, Herba Leonuri 12g, Radix Achyranthis Bidentatae 9g, Caulis Spatholobi 5g, Fructus Amomi Rotundus 10g, Cortex Magnoliae Officinalis 15g, Lignum Santali Albi 7g, Rhizoma Cyperi 5g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.
Embodiment three: take by weighing Rhizoma Chuanxiong 7g, Rhizoma Corydalis 12g, Radix Curcumae 6g, Herba Leonuri 15g, Radix Achyranthis Bidentatae 7g, Caulis Spatholobi 7g, Fructus Amomi Rotundus 12g, Cortex Magnoliae Officinalis 12g, Lignum Santali Albi 9g, Rhizoma Cyperi 7g.Add water 500mL, steep first 20min, intense fire boils 30min, gets liquid 200mL, and is oral.
Claims (2)
1. treatment qi stagnation and blood stasis type prostatitic Chinese medicine QIANLIEKANG decoction is characterized in that this Chinese medicine QIANLIEKANG decoction made by the Chinese medicine of following weight portion: Rhizoma Chuanxiong 7-9 part, Rhizoma Corydalis 10-12 part, Radix Curcumae 6-8 part, Herba Leonuri 12-15 part, Radix Achyranthis Bidentatae 7-9 part, Caulis Spatholobi 5-7 part, Fructus Amomi Rotundus 10-12 part, Cortex Magnoliae Officinalis 12-15 part, Lignum Santali Albi 7-9 part, Rhizoma Cyperi 5-7 part.
2. a kind of prostatitic Chinese medicine QIANLIEKANG of qi stagnation and blood stasis type decoction for the treatment of according to claim 1 is characterized in that this Chinese medicine QIANLIEKANG decoction made by the Chinese medicine of following weight portion: 8 parts of Rhizoma Chuanxiongs, 11 parts of Rhizoma Corydalis, 7 parts of Radix Curcumaes, 13 parts of Herba Leonuris, 8 parts of Radix Achyranthis Bidentataes, 6 parts of Caulis Spatholobis, 11 parts of Fructus Amomi Rotunduss, 13 parts of Cortex Magnoliae Officinalis, 8 parts in Lignum Santali Albi, 6 parts of Rhizoma Cyperis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210022711XA CN103028080A (en) | 2012-01-04 | 2012-01-04 | Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210022711XA CN103028080A (en) | 2012-01-04 | 2012-01-04 | Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103028080A true CN103028080A (en) | 2013-04-10 |
Family
ID=48015809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210022711XA Pending CN103028080A (en) | 2012-01-04 | 2012-01-04 | Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103028080A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997999A (en) * | 2015-08-19 | 2015-10-28 | 刘向荣 | Traditional Chinese medicine composition for treating chronic prostatitis |
CN105012621A (en) * | 2015-08-19 | 2015-11-04 | 刘向荣 | Traditional Chinese medicine composition for treating chronic prostatitis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1753682A (en) * | 2003-01-16 | 2006-03-29 | 利盛私人有限公司 | The herbal-composition that is used for prostatosis |
CN101125186A (en) * | 2006-09-11 | 2008-02-20 | 蔡胜华 | Chinese medicine for treating prostatitis |
CN101129870A (en) * | 2007-08-22 | 2008-02-27 | 陕西东泰制药有限公司 | Medicine for treating prostatic hyperplasia and preparation method thereof |
-
2012
- 2012-01-04 CN CN201210022711XA patent/CN103028080A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1753682A (en) * | 2003-01-16 | 2006-03-29 | 利盛私人有限公司 | The herbal-composition that is used for prostatosis |
CN101125186A (en) * | 2006-09-11 | 2008-02-20 | 蔡胜华 | Chinese medicine for treating prostatitis |
CN101129870A (en) * | 2007-08-22 | 2008-02-27 | 陕西东泰制药有限公司 | Medicine for treating prostatic hyperplasia and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
何清湖,陈军: "中医药治疗前列腺增生症研究进展", 《湖南中医药导报》 * |
张西相等: "补肾八法治疗慢性泌尿系疾病", 《河北中医》 * |
王益平等: "名中医诊治慢性前列腺炎的经验及思路探析", 《中国中医基础医学杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104997999A (en) * | 2015-08-19 | 2015-10-28 | 刘向荣 | Traditional Chinese medicine composition for treating chronic prostatitis |
CN105012621A (en) * | 2015-08-19 | 2015-11-04 | 刘向荣 | Traditional Chinese medicine composition for treating chronic prostatitis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099944A (en) | Drug for treating stubborn insomnia | |
CN102462834A (en) | Medicinal composition for controlling blood sugar of diabetic | |
CN104189128A (en) | Traditional Chinese medicine fumigation lotion for treating diabetic peripheral neuropathy | |
CN103690605A (en) | Traditional Chinese medicine preparation for treating rheumatism | |
CN103877334A (en) | Chinese medicinal liquor for treating rheumatoid arthritis and preparation method thereof | |
CN103028080A (en) | Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis | |
CN103933171B (en) | A kind of External apply medicinal wine for the treatment of lumbago and skelalgia | |
CN103083452A (en) | Traditional Chinese medicine for treating chronic bacterial prostatitis | |
CN100464770C (en) | A medicine for treating chronic prostatitis and preparation method thereof | |
CN102988900B (en) | Traditional Chinese medicine enema used for treating senile functional constipation | |
CN104258362A (en) | Traditional Chinese medicine preparation for treating peripheral neuritis | |
CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
CN102988788A (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease and clysis nursing method | |
CN103239565B (en) | Wind-dispelling and spur-removing soup for treating arthralgia and preparation method of soup | |
CN104940503A (en) | Traditional Chinese medicine combination for treating itchy skins of patients undergoing hemodialysis | |
CN103751293A (en) | Traditional Chinese medicinal composition for treating chronic nephritis | |
CN103656378A (en) | Traditional Chinese medicine agent for treatment of acute gouty arthritis | |
CN108272861A (en) | A kind of Chinese traditional medicine lotion for treating de Quervain disease | |
CN103705646B (en) | A kind of Chinese medicinal enema treating ulcerative colitis | |
CN102283925A (en) | Traditional Chinese medicine for treating neurodynia resulted from herpes zoster | |
CN104740431A (en) | Drug for treating cervical and lumbar diseases | |
CN105687433A (en) | Traditional Chinese medicinal preparation for treating skin psoriasis | |
CN103845499B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
CN105232744A (en) | Traditional Chinese medicine composition for treating lumbago | |
CN104306734A (en) | Plaster preparation for external use for treating diabetic gangrene and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130410 |